Canadian guideline for Parkinson disease

Overview of attention for article published in Canadian Medical Association Journal, September 2019

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (98th percentile)
High Attention Score compared to outputs of the same age and source (92nd percentile)

Mentioned by

news: 5 news outlets
blogs: 3 blogs
policy: 2 policy sources

twitter: 95 X users
facebook: 5 Facebook pages

Citations

dimensions_citation: 93 Dimensions

Readers on

mendeley: 301 Mendeley

Summary News Blogs Policy documents X Facebook Dimensions citations

So far, Altmetric has seen 5 policy documents that reference this research output.

foslevodopa foscarbidopa

Cited by Canadian Agency for Drugs and Technologies in Health on 13 Sep 2023

CADTH is an independent, not-for-profit organization responsible for providing health care decision-makers with objective evidence to help make informed decisions about the optimal use of health technologies.

Deep Brain Stimulation Surgery Programs in Canada

Cited by Canadian Agency for Drugs and Technologies in Health on 13 Jun 2023

Parkinson disease: a public health approach: technical brief

Cited by World Health Organization on 13 Jun 2022

The World Health Organization (WHO) is the directing and coordinating authority for health within the United Nations system.

DaTscan for Diagnosing Movement Disorders

Cited by Canadian Agency for Drugs and Technologies in Health on 26 Aug 2021

This page shows the most recent policy documents that mention this research output.

Click here to find out how to access more activity, including 1 additional policy documents.